These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18946956)
61. Preliminary results of Rh-prophylaxis during pregnancy. Baumgarten K; Reinold E Pathologica; 1972; 64(929):115-8. PubMed ID: 4210235 [No Abstract] [Full Text] [Related]
62. The use of Rh immune globulin: a review. Sutton GP; Jay A; Lim YS; Noland JE; Boral LI Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434 [No Abstract] [Full Text] [Related]
63. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss. Crane JP; Kopta MM Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172 [TBL] [Abstract][Full Text] [Related]
64. Follow-up of 2000 second-trimester amniocenteses. Crandall BF; Howard J; Lebherz TB; Rubinstein L; Sample WF; Sarti D Obstet Gynecol; 1980 Nov; 56(5):625-8. PubMed ID: 7432734 [TBL] [Abstract][Full Text] [Related]
65. Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital. Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C J Med Assoc Thai; 2008 Nov; 91(11):1639-43. PubMed ID: 19127782 [TBL] [Abstract][Full Text] [Related]
67. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies. Leschot NJ; Verjaal M; Treffers PE Br J Obstet Gynaecol; 1985 Aug; 92(8):804-7. PubMed ID: 4027202 [TBL] [Abstract][Full Text] [Related]
68. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C. Trevett TN; Moise KJ Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562 [TBL] [Abstract][Full Text] [Related]
70. Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Wapner RJ; Johnson A; Davis G; Urban A; Morgan P; Jackson L Obstet Gynecol; 1993 Jul; 82(1):49-56. PubMed ID: 8515925 [TBL] [Abstract][Full Text] [Related]
71. Immunoprophylaxis with anti D immunoglobulins in Rh negative women. Gupta I; Jolly JG; Gupta AN Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352 [No Abstract] [Full Text] [Related]
73. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383 [TBL] [Abstract][Full Text] [Related]
74. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus. Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570 [TBL] [Abstract][Full Text] [Related]
75. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses. Sant-Cassia LJ; MacPherson MB; Tyack AJ Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566 [TBL] [Abstract][Full Text] [Related]
77. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
78. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn]. Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074 [TBL] [Abstract][Full Text] [Related]
79. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin. Thornton JG; Page C; Foote G; Arthur GR; Tovey LA; Scott JS BMJ; 1989 Jun; 298(6689):1671-3. PubMed ID: 2547468 [TBL] [Abstract][Full Text] [Related]